EYEGATE PHARMACEUTICALS INC 4
4 · EYEGATE PHARMACEUTICALS INC · Filed Jan 27, 2016
Insider Transaction Report
Form 4
MALFROY-CAMINE BERNARD
Director
Transactions
- Award
Stock Option (right to buy)
2016-01-25+3,000→ 3,000 totalExercise: $1.70Exp: 2026-01-25→ Common Stock (3,000 underlying)
Footnotes (1)
- [F1]The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on January 25, 2017, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years.